Geibprasert Sasikhan, Krings Timo, Armstrong Derek, Terbrugge Karel G, Raybaud Charles A
Neuroradiology Division, Department of Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada, M5G 1X8.
Childs Nerv Syst. 2010 Jan;26(1):35-46. doi: 10.1007/s00381-009-0959-7. Epub 2009 Aug 7.
Vein of Galen aneurysmal malformations (VGAMs) are choroidal arteriovenous malformations that develop during an early embryonic stage. Although recent reports have shown improved outcome for these patients, the overall outcome still is poor. In this study, we evaluated the clinical, imaging, and angiographic features that may predict the outcome in VGAM patients.
Twenty-five patients diagnosed with VGAM were reviewed for clinical symptoms, including neonatal scoring systems, imaging findings, angioarchitecture, treatment decision, initial treatment age, follow-up timing, and follow-up outcome.
Factors that were significantly associated with a poor outcome (p < 0.05) included neurological symptoms at presentation, a medium-to-low overall neonatal score (<12/21), a very poor score (<2/5) in one (or more) categories, focal parenchymal changes, calcifications, tonsillar herniation, arterial steal, or more than two groups of multiple arterial feeders. The venous drainage pattern and treatment age were not significantly associated with the overall outcome.
The presence of multiple factors that are related with poor outcome may warrant withholding aggressive treatment, while a small subgroup of carefully selected patients without any of these factors who are clinically asymptomatic may have a good outcome even with conservative management and close follow-up. For all other patients in which treatment is considered, the optimal treatment time is at 4-5 months of age; however, urgent treatment, regardless of age, should be indicated in those that do not have permanent brain damage on imaging with deteriorating congestive heart failure, evidence of arterial steal, or progressive occlusion of the venous outflow.
大脑大静脉动脉瘤样畸形(VGAMs)是在胚胎早期发育过程中形成的脉络膜动静脉畸形。尽管最近的报告显示这些患者的预后有所改善,但总体预后仍然较差。在本研究中,我们评估了可能预测VGAM患者预后的临床、影像学和血管造影特征。
回顾了25例诊断为VGAM的患者的临床症状,包括新生儿评分系统、影像学表现、血管构筑、治疗决策、初始治疗年龄、随访时间和随访结果。
与预后不良显著相关(p<0.05)的因素包括就诊时的神经症状、总体新生儿评分中低(<12/21)、一个(或多个)类别评分极差(<2/5)、局灶性实质改变、钙化、扁桃体疝、动脉盗血或两组以上的多条动脉供血。静脉引流模式和治疗年龄与总体预后无显著相关性。
存在与预后不良相关的多种因素可能需要避免积极治疗,而一小部分精心挑选的无任何这些因素且临床无症状的患者即使采用保守治疗和密切随访也可能有良好的预后。对于所有其他考虑治疗的患者,最佳治疗时间是4至5个月龄;然而,对于影像学上没有永久性脑损伤但伴有充血性心力衰竭恶化、动脉盗血证据或静脉流出道进行性闭塞的患者,无论年龄大小,都应进行紧急治疗。